The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy

OBJECTIVE: To assess whether neuropathy with anti-myelin-associated glycoprotein (MAG) antibody may improve after treatment with ibrutinib, an oral inhibitor of Bruton tyrosine kinase, we prospectively treated with ibrutinib a cohort of 3 patients with anti-MAG neuropathy and Waldenström macroglobul...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellani, Francesca, Visentin, Andrea, Campagnolo, Marta, Salvalaggio, Alessandro, Cacciavillani, Mario, Candiotto, Cinzia, Bertorelle, Roberta, Trentin, Livio, Briani, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176252/
https://www.ncbi.nlm.nih.gov/pubmed/32284437
http://dx.doi.org/10.1212/NXI.0000000000000720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176252/
https://www.ncbi.nlm.nih.gov/pubmed/32284437
http://dx.doi.org/10.1212/NXI.0000000000000720

Ejemplares similares